Activation of the Central Renin-Angiotensin System Causes Local Cerebrovascular Dysfunction

• Published in: Stroke (1970) 2021-07, Vol.52 (7), p.2404-2413
• Main Authors: De Silva, T. Michael, Modrick, Mary L., Grobe, Justin L., Faraci, Frank M.
• Format: Article
• Language: English
• Subjects: Animals; Cerebrovascular Disorders - chemically induced; Cerebrovascular Disorders - genetics; Cerebrovascular Disorders - metabolism; Desoxycorticosterone Acetate - toxicity; Endothelium, Vascular - metabolism; Female; Hypertension - chemically induced; Hypertension - genetics; Hypertension - metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase Type III - biosynthesis; Nitric Oxide Synthase Type III - genetics; Receptor, Angiotensin, Type 1 - biosynthesis; Receptor, Angiotensin, Type 1 - genetics; Renin-Angiotensin System - drug effects; Renin-Angiotensin System - physiology
• ISSN: 0039-2499; 1524-4628
• DOI: 10.1161/STROKEAHA.121.034984

Hypertension is a leading risk factor for cerebrovascular disease and loss of brain health. While the brain renin-angiotensin system (RAS) contributes to hypertension, its potential impact on the local vasculature is unclear. We tested the hypothesis that activation of the brain RAS would alter the local vasculature using a modified deoxycorticosterone acetate (DOCA) model. C57BL/6 mice treated with DOCA (50 mg SQ; or shams) were given tap H2O and H2O with 0.9% NaCl for 1 to 3 weeks. In isolated cerebral arteries and parenchymal arterioles from DOCA-treated male mice, endothelium- and nitric oxide-dependent dilation was progressively impaired, while mesenteric arteries were unaffected. In contrast, cerebral endothelial function was not significantly affected in female mice treated with DOCA. In males, mRNA expression of renal Ren1 was markedly reduced while RAS components (eg, Agt and Ace) were increased in both brain and cerebral arteries with central RAS activation. In NZ44 reporter mice expressing GFP (green fluorescent protein) driven by the angiotensin II type 1A receptor (Agtr1a) promoter, DOCA increased GFP expression ≈3-fold in cerebral arteries. Impaired endothelial responses were restored to normal by losartan, an AT1R (angiotensin II type 1 receptor) antagonist. Last, DOCA treatment produced inward remodeling of parenchymal arterioles. These findings suggest activation of the central and cerebrovascular RAS impairs endothelial (nitric oxide dependent) signaling in brain through expression and activation of AT1R and sex-dependent effects. The central RAS may be a key contributor to vascular dysfunction in brain in a preclinical (low renin) model of hypertension. Because the brain RAS is also activated during aging and other diseases, a common mechanism may promote loss of endothelial and brain health despite diverse cause.